AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 10th, 2021 • New Leaf Biopharma Opportunities I, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 10th, 2021 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Shares of Addex Therapeutics Ltd.